The phenomenon of crosstalk between PI3K/AKT and MEK/ERK pathways was analyzed by using inhibitors of molecules of these signaling pathways alone or in combination with cisplatin in a panel of lung cancer-derived primary cell lines. This evidence concerns the gene MAP2K7 and lung cancer.